Though no specific data on the At5g03100 antibody exists in the provided sources, recombinant monoclonal antibody (mAb) workflows (e.g., hybridoma technology, phage display) are standardized for plant proteins . Key steps include:
Antigen Production: Expressing the At5g03100 protein or its epitope in bacterial/plant systems.
Immunization: Administering the antigen to host species (e.g., rabbits, mice).
Screening: Using ELISA or Western blot to identify high-affinity clones .
Validation: Testing specificity via knockout (KO) plant lines or immunoprecipitation .
| Parameter | Method | Target Threshold |
|---|---|---|
| Specificity | Western blot (KO validation) | No band in KO samples |
| Affinity | Surface plasmon resonance (SPR) | KD ≤ 10 nM |
| Cross-reactivity | Immunofluorescence (IF) | Signal only in target tissues |
| Batch Consistency | SDS-PAGE | ≥95% purity |
Antibodies against plant F-box proteins like At5g03100 enable:
Protein Localization Studies: Tracking subcellular dynamics via IF .
Interaction Mapping: Co-immunoprecipitation (Co-IP) to identify binding partners (e.g., GI, ZTL) .
Functional Knockdown: Antibody-mediated inhibition to study phenotypic effects (e.g., delayed flowering) .
Plant Material: Arabidopsis seedlings under controlled photoperiods.
Protein Extraction: Total protein isolation from shoots/roots.
Western Blot: Using At5g03100 antibody to detect expression levels.
Phenotypic Analysis: Correlating protein abundance with flowering time.
Characterization Gaps: ~50% of commercial antibodies lack sufficient validation .
Cross-Species Reactivity: Antibodies for Arabidopsis proteins may not bind homologs in crops like Nicotiana .
High-Throughput Demand: Projects like the EU’s Affinomics initiative aim to scale antibody generation for plant proteomes .